Apomedica Pharmazeutische Produkte GmbH in Beauty and Personal Care (Austria)

October 2013 | 3 pages | ID: A14FF720102EN
Euromonitor International Ltd

Abstracts

Apomedica Pharmazeutische Produkte GmbH is expected to continue following a twofold strategy of blurring the lines between medicated skin care with a cosmetic positioning and skin care positioned as medicated. The company is likely to continue using its traditional recipes and state-of-the-art medical and pharmaceutical research results in order to create beauty and personal care positioned as medicated thus expanding further into beauty and personal care with its Lasepton brand.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Baby and Child-specific Products, Bath and Shower, Colour Cosmetics, Deodorants, Depilatories, Fragrances, Hair Care, Mass Cosmetics, Men's Grooming, Oral Care, Oral Care Excl Power Toothbrushes, Premium Cosmetics, Sets/Kits, Skin Care, Sun Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Beauty and Personal Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Apomedica Pharmazeutische Produkte GmbH: Key Facts
Summary 2 Apomedica Pharmazeutische Produkte GmbH: Operational Indicators
Company Background
Production
Summary 3 Apomedica Pharmazeutische Produkte GmbH: Production Sites 2012
Competitive Positioning
Summary 4 Apomedica Pharmazeutische Produkte GmbH: Competitive Position 2012